EUVIMEDEUVIMED entdecken
Crossref

Broussonin E against acute respiratory distress syndrome: the potential roles of anti-inflammatory

Ning Wang, Guangcheng Sun, Qiaoyun Zhang, Qian Gao, Bingjie Wang, Lingling Guo, Gao Cheng, Yuexia Hu, Jian Huang, Ruguo Ren, Chunhui Wang, Chen Chen

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-023-02801-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Ning Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University and Anhui Public Health Clinical Center, Xinzhan District, No…. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Molecular Docking Simulation, Anti-Inflammatory Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Anhui Public Health Clinical Center Scientific Research Cultivating Fund, National Natural Science Foundation of China, Research Fund of Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We applied network pharmacology and molecular docking analyses to study the efficacy of Broussonin E (BRE) in acute respiratory distress syndrome (ARDS) treatment and to determine the core components, potential targets, and mechanism of action of BRE. The SwissTargetprediction and SEA databases were used to predict BRE targets, and the GeneCards and OMIM databases were used to predict ARDS-related genes. The drug targets and disease targets were mapped to obtain an intersecting drug target gene network, which was then uploaded into the String database for protein-protein interaction network analysis. The intersecting gene was also uploaded into the DAVID database for gene ontology enrichment analysis and Kyoto encyclopedia of genes and genomes pathway analysis. Molecular docking analysis was performed to verify the interaction of BRE with the key targets. Finally, to validate the experiment in vivo, we established an oleic acid-induced ARDS rat model and evaluated the protective effect of BRE on ARDS by histological evaluation and enzyme-linked immunosorbent assay. Overall, 79 targets of BRE and 3974 targets of ARDS were predicted, and 79 targets were obtained after intersection. Key genes such as HSP90AA1, JUN, ESR1, MTOR, and PIK3CA play important roles in the nucleus and cytoplasm by regulating the tumor necrosis factor, nuclear factor-κB, and PI3K-Akt signaling pathways. Molecular docking results showed that small molecules of BRE could freely bind to the active site of the target proteins. In vivo experiments showed that BRE could reduce ARDS-related histopathological changes, release of inflammatory factors, and infiltration of macrophages and oxidative stress reaction. BRE exerts its therapeutic effect on ARDS through target and multiple pathways. This study also predicted the potential mechanism of BRE on ARDS, which provides the theoretical basis for in-depth and comprehensive studies of BRE treatment on ARDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Distress SyndromeMolecular Docking SimulationAnti-Inflammatory AgentsAnimalsMaleRats, Sprague-DawleyNetwork PharmacologyRatsProtein Interaction MapsSignal TransductionDisease Models, AnimalLung

Stichwörter der Autor:innen

ARDSBroussonin EInflammationMolecular dockingNetwork analysis

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University and Anhui Public Health Clinical Center, Xinzhan District, No.100, Huaihai Road, Hefei, 230011, Anhui, China.
  • Department of Cardiology, Anhui Chest Hospital, Hefei, Anhui, China.
  • Department of Genetics, School of Life Science, Anhui Medical University, Hefei, Anhui, China.
  • Department of Thoracic Surgery, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, No.17, Lujiang Road, Luyang District, Hefei, 230001, Anhui, C…
  • Department of Cardiovascular Hospital, Xi'an No.1 Hospital and The First Affiliated Hospital of Northwest University, Beilin District, No.30, South Street powder Lane, Xi'an, 710002, Shaanxi, China. aru1989@163.com.
  • Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University and Anhui Public Health Clinical Center, Xinzhan District, No.100, Huaihai Road, Hefei, 230011, Anhui, China. wangchhaymz@163.com.

Förderung

  • Anhui Public Health Clinical Center Scientific Research Cultivating Fund
  • National Natural Science Foundation of China
  • Research Fund of Anhui Medical University
  • Basic and Clinical Cooperative Research Promotion Program of Anhui Medical University
  • Open Research fund of Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University

Zitieren

APA

Wang, N., Sun, G., Zhang, Q., Gao, Q., Wang, B., Guo, L., Cheng, G., Hu, Y., Huang, J., Ren, R., Wang, C., & Chen, C. (2024). Broussonin E against acute respiratory distress syndrome: the potential roles of anti-inflammatory. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-023-02801-1

Vancouver

Wang N, Sun G, Zhang Q, Gao Q, Wang B, Guo L, et al. Broussonin E against acute respiratory distress syndrome: the potential roles of anti-inflammatory. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-023-02801-1

BibTeX
@article{Wang2024,
  author = {Wang, Ning and Sun, Guangcheng and Zhang, Qiaoyun and Gao, Qian and Wang, Bingjie and Guo, Lingling and Cheng, Gao and Hu, Yuexia and Huang, Jian and Ren, Ruguo and Wang, Chunhui and Chen, Chen},
  title = {Broussonin E against acute respiratory distress syndrome: the potential roles of anti-inflammatory},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-023-02801-1}
}
Kostenlos starten →